US Patent Issued to NORTON (WATERFORD) on May 27 for "Inhalable formulation of fluticasone propionate and albuterol sulfate" (Irish Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,979, issued on May 27, was assigned to NORTON (WATERFORD) Ltd. (Waterford, Ireland).

"Inhalable formulation of fluticasone propionate and albuterol sulfate" was invented by Brian Paul O'Neill (Waterford, Ireland), Hardik Kirtikumar Shah (Waterford, Ireland), Julian Alexander Blair (Waterford, Ireland), Chris David Edlin (Waterford, Ireland) and Shane Michael McKeon (Waterford, Ireland).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to a fixed-dose dry powder inhalation formulation comprising fluticasone propionate and albuterol sulfate, together with an Alpha-lactose monohydrate carrier. In the formulation, the albuterol sulfat...